U.S. flag

An official website of the United States government

NM_001130987.2(DYSF):c.5830C>T (p.Arg1944Ter) AND not provided

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Dec 13, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000080312.16

Allele description [Variation Report for NM_001130987.2(DYSF):c.5830C>T (p.Arg1944Ter)]

NM_001130987.2(DYSF):c.5830C>T (p.Arg1944Ter)

Gene:
DYSF:dysferlin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p13.2
Genomic location:
Preferred name:
NM_001130987.2(DYSF):c.5830C>T (p.Arg1944Ter)
Other names:
6086C>T
HGVS:
  • NC_000002.12:g.71674242C>T
  • NG_008694.1:g.225620C>T
  • NM_001130455.2:c.5716C>T
  • NM_001130976.2:c.5671C>T
  • NM_001130977.2:c.5734C>T
  • NM_001130978.2:c.5776C>T
  • NM_001130979.2:c.5806C>T
  • NM_001130980.2:c.5764C>T
  • NM_001130981.2:c.5827C>T
  • NM_001130982.2:c.5809C>T
  • NM_001130983.2:c.5779C>T
  • NM_001130984.2:c.5737C>T
  • NM_001130985.2:c.5767C>T
  • NM_001130986.2:c.5674C>T
  • NM_001130987.2:c.5830C>TMANE SELECT
  • NM_003494.4:c.5713C>T
  • NP_001123927.1:p.Arg1906Ter
  • NP_001124448.1:p.Arg1891Ter
  • NP_001124449.1:p.Arg1912Ter
  • NP_001124450.1:p.Arg1926Ter
  • NP_001124451.1:p.Arg1936Ter
  • NP_001124452.1:p.Arg1922Ter
  • NP_001124453.1:p.Arg1943Ter
  • NP_001124454.1:p.Arg1937Ter
  • NP_001124455.1:p.Arg1927Ter
  • NP_001124456.1:p.Arg1913Ter
  • NP_001124457.1:p.Arg1923Ter
  • NP_001124458.1:p.Arg1892Ter
  • NP_001124459.1:p.Arg1944Ter
  • NP_003485.1:p.Arg1905Ter
  • LRG_845t1:c.5713C>T
  • LRG_845t2:c.5830C>T
  • LRG_845:g.225620C>T
  • LRG_845p1:p.Arg1905Ter
  • LRG_845p2:p.Arg1944Ter
  • NC_000002.11:g.71901372C>T
  • NM_001130987.2:c.5830C>T
  • NM_003494.3:c.5713C>T
  • NP_003485.1:p.Arg1905*
Protein change:
R1891*; ARG1905TER
Links:
OMIM: 603009.0012; dbSNP: rs121908959
NCBI 1000 Genomes Browser:
rs121908959
Molecular consequence:
  • NM_001130455.2:c.5716C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130976.2:c.5671C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130977.2:c.5734C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130978.2:c.5776C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130979.2:c.5806C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130980.2:c.5764C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130981.2:c.5827C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130982.2:c.5809C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130983.2:c.5779C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130984.2:c.5737C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130985.2:c.5767C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130986.2:c.5674C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001130987.2:c.5830C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_003494.4:c.5713C>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
4

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000335577Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Pathogenic
(Sep 22, 2015)
germlineclinical testing

Citation Link,

SCV000613217Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Pathogenic
(Mar 7, 2023)
unknownclinical testing

PubMed (13)
[See all records that cite these PMIDs]

SCV000680751GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Mar 24, 2023)
germlineclinical testing

Citation Link,

SCV002021876Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Dec 13, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknown4not providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.

Vilchez JJ, Gallano P, Gallardo E, Lasa A, Rojas-García R, Freixas A, De Luna N, Calafell F, Sevilla T, Mayordomo F, Baiget M, Illa I.

Arch Neurol. 2005 Aug;62(8):1256-9.

PubMed [citation]
PMID:
16087766

Dysferlin expression in monocytes: a source of mRNA for mutation analysis.

De Luna N, Freixas A, Gallano P, Caselles L, Rojas-García R, Paradas C, Nogales G, Dominguez-Perles R, Gonzalez-Quereda L, Vílchez JJ, Márquez C, Bautista J, Guerrero A, Salazar JA, Pou A, Illa I, Gallardo E.

Neuromuscul Disord. 2007 Jan;17(1):69-76. Epub 2006 Oct 27.

PubMed [citation]
PMID:
17070050
See all PubMed Citations (14)

Details of each submission

From Eurofins Ntd Llc (ga), SCV000335577.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided4not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided4not providednot providednot provided

From Athena Diagnostics, SCV000613217.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (13)

Description

This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). In multiple individuals with Miyoshi muscular dystrophy, this variant has been seen with a single recessive pathogenic variant in the same gene, suggesting this variant may also be pathogenic. This variant is a common founder originating from Sueca, Spain (PMID: 16087766).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV000680751.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 16010686, 32400077, 33250842, 33215690, 30919934, 33715265, 31069529, 34559919, 33348118, 33610434, 20558759, 16087766)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Revvity Omics, Revvity, SCV002021876.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024